Accent Therapeutics, Inc.

Accent Therapeutics, Inc.

Accent Therapeutics, Inc.

Accent is developing oncology-focused, small molecule therapies targeting RNA-modifying proteins in the emerging field of epitranscriptomics.
Raised
$40M
Follow us
Alexa global traffic share